标题
Personalized Management of Pheochromocytoma and Paraganglioma
作者
关键词
-
出版物
ENDOCRINE REVIEWS
Volume -, Issue -, Pages -
出版商
The Endocrine Society
发表日期
2021-06-20
DOI
10.1210/endrev/bnab019
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Mitochondrial DNA alterations underlie an irreversible shift to aerobic glycolysis in fumarate hydratase–deficient renal cancer
- (2021) Daniel R. Crooks et al. Science Signaling
- Misleading 68 GALLIUM‐dotatate PET scan in a patient with a history of a phaeochromocytoma: Unsuspected uptake in papillary thyroid carcinoma metastases
- (2021) Daniel Moffat et al. JOURNAL OF NEUROENDOCRINOLOGY
- Mastermind Like Transcriptional Coactivator 3 (MAML3) drives neuroendocrine tumor progression
- (2021) Nathaniel Alzofon et al. MOLECULAR CANCER RESEARCH
- International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers
- (2021) Laurence Amar et al. Nature Reviews Endocrinology
- Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine/Head and Neck Disease-Site Work Group. Part 1 of 2: Advances in Pathogenesis and Diagnosis of Pheochromocytoma and Paraganglioma
- (2020) Dhaval Patel et al. ANNALS OF SURGICAL ONCOLOGY
- Metastatic pheochromocytoma and paraganglioma: proceedings of the MEN2019 workshop
- (2020) Patricia Dahia et al. ENDOCRINE-RELATED CANCER
- Clinical characteristics and outcomes of SDHB-related pheochromocytoma and paraganglioma in children and adolescents
- (2020) Ivana Jochmanova et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Screening guidelines and recommendations for patients at high risk of developing endocrine cancers
- (2020) Jennifer L. Geurts et al. JOURNAL OF SURGICAL ONCOLOGY
- Inhibition of Wnt/β-Catenin Signaling in Neuroendocrine Tumors In Vitro: Antitumoral Effects
- (2020) Xi-Feng Jin et al. Cancers
- An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma
- (2020) Alexandre Buffet et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma
- (2020) Jacques W.M. Lenders et al. JOURNAL OF HYPERTENSION
- Metabolomics, machine learning and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomas
- (2020) Paal W. Wallace et al. JOURNAL OF PATHOLOGY
- TET-Mediated Hypermethylation Primes SDH-Deficient Cells for HIF2α-Driven Mesenchymal Transition
- (2020) Aurélie Morin et al. Cell Reports
- Phase 2 study of pembrolizumab in patients with advanced rare cancers
- (2020) Aung Naing et al. Journal for ImmunoTherapy of Cancer
- HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: History of the multiple endocrine neoplasia workshops and overview of MEN2019
- (2020) Elizabeth Grubbs et al. ENDOCRINE-RELATED CANCER
- Sino-European differences in the genetic landscape and clinical presentation of pheochromocytoma and paraganglioma
- (2020) Jingjing Jiang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Approach to the Patient: Perioperative Management of the Patient with Pheochromocytoma or Sympathetic Paraganglioma
- (2020) Annika M A Berends et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- 177Lu-DOTATATE therapy in metastatic/inoperable pheochromocytoma-paraganglioma
- (2020) Sanjeet Kumar Jaiswal et al. Endocrine Connections
- Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paraganglioma
- (2020) Graeme Eisenhofer et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Phase II Clinical Trial of Pembrolizumab in Patients with Progressive Metastatic Pheochromocytomas and Paragangliomas
- (2020) Camilo Jimenez et al. Cancers
- Multiple Endocrine Tumors Associated with Germline MAX Mutations: Multiple Endocrine Neoplasia Type 5?
- (2020) Amanda J Seabrook et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Clinical, Diagnostic, and Treatment Characteristics of SDHA-Related Metastatic Pheochromocytoma and Paraganglioma
- (2019) Abhishek Jha et al. Frontiers in Oncology
- Efficacy and Safety of Ablative Therapy in the Treatment of Patients with Metastatic Pheochromocytoma and Paraganglioma
- (2019) Jacob Kohlenberg et al. Cancers
- The Value of Histological Algorithms to Predict the Malignancy Potential of Pheochromocytomas and Abdominal Paragangliomas—A Meta-Analysis and Systematic Review of the Literature
- (2019) Adam Stenman et al. Cancers
- An analysis of surveillance screening for SDHB-related disease in childhood and adolescence
- (2019) Nicola Tufton et al. Endocrine Connections
- Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas
- (2019) Madhav Prasad Yadav et al. EJNMMI Research
- Positive Impact of Genetic Test on the Management and Outcome of Patients With Paraganglioma and/or Pheochromocytoma
- (2019) Alexandre Buffet et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Prognosis of malignant pheochromocytoma and paraganglioma (MAPP-Prono study): an ENS@T retrospective study
- (2019) Segolene Hescot et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Genotype-phenotype correlations in pheochromocytoma and paraganglioma
- (2019) Joakim Crona et al. ENDOCRINE-RELATED CANCER
- Recurrent Germline DLST Mutations in Individuals with Multiple Pheochromocytomas and Paragangliomas
- (2019) Laura Remacha et al. AMERICAN JOURNAL OF HUMAN GENETICS
- A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial
- (2019) Grainne M O’Kane et al. BRITISH JOURNAL OF CANCER
- Treatment of inoperable or metastatic paragangliomas and pheochromocytomas with peptide receptor radionuclide therapy using 177Lu-DOTATATE
- (2019) Wouter Thomas Zandee et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Chromogranin A in the Laboratory Diagnosis of Pheochromocytoma and Paraganglioma
- (2019) Bílek et al. Cancers
- A high rate of modestly elevated plasma normetanephrine in a population referred for suspected PPGL when measured in a seated position
- (2019) Jessica Boyd et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma
- (2019) David Taïeb et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Distinct modes of mitochondrial metabolism uncouple T cell differentiation and function
- (2019) Will Bailis et al. NATURE
- A phase I clinical trial for [131I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma
- (2019) Hiroshi Wakabayashi et al. Scientific Reports
- Optimizing Genetic Workup in Pheochromocytoma and Paraganglioma by Integrating Diagnostic and Research Approaches
- (2019) Laura Gieldon et al. Cancers
- Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with 177Lu-DOTATATE
- (2019) Achyut Ram Vyakaranam et al. Cancers
- Peptide Receptor Radionuclide Therapy in the Management of Advanced Pheochromocytoma and Paraganglioma: A Systematic Review and Meta‐analysis
- (2019) Swayamjeet Satapathy et al. CLINICAL ENDOCRINOLOGY
- Molecular imaging and radionuclide therapy of paraganglioma and pheochromocytoma
- (2019) David Taieb et al. ENDOCRINE-RELATED CANCER
- Pheochromocytoma and paraganglioma: clinical feature-based disease probability in relation to catecholamine biochemistry and reason for disease suspicion
- (2019) Aikaterini Geroula et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Broadening horizons with 225Ac-DOTATATE targeted alpha therapy for gastroenteropancreatic neuroendocrine tumour patients stable or refractory to 177Lu-DOTATATE PRRT: first clinical experience on the efficacy and safety
- (2019) Sanjana Ballal et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Long-term outcomes of 125 patients with metastatic pheochromocytoma or paraganglioma treated with 131I-mIBG
- (2019) Matthew P Thorpe et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Efficacy of α-blockers on hemodynamic control during pheochromocytoma resection - a randomized controlled trial
- (2019) Edward Buitenwerf et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Risk of metastatic pheochromocytoma and paraganglioma in SDHx mutation carriers: a systematic review and updated meta-analysis
- (2019) Hansong Lee et al. JOURNAL OF MEDICAL GENETICS
- Diagnostic Accuracy of Computed Tomography to Exclude Pheochromocytoma: A Systematic Review, Meta-analysis, and Cost Analysis
- (2019) Edward Buitenwerf et al. MAYO CLINIC PROCEEDINGS
- Current Management of Pheochromocytoma/Paraganglioma: A Guide for the Practicing Clinician in the Era of Precision Medicine
- (2019) Nölting et al. Cancers
- A novel splicing site IRP1 somatic mutation in a patient with pheochromocytoma and JAK2V617F positive polycythemia vera: a case report
- (2018) Ying Pang et al. BMC CANCER
- Germline Mutations in the Mitochondrial 2-Oxoglutarate/Malate CarrierSLC25A11Gene Confer a Predisposition to Metastatic Paragangliomas
- (2018) Alexandre Buffet et al. CANCER RESEARCH
- Continued Tumor Reduction of Metastatic Pheochromocytoma/Paraganglioma Harboring Succinate Dehydrogenase Subunit B Mutations with Cyclical Chemotherapy
- (2018) Irfan Jawed et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Targeting NAD+/PARP DNA Repair Pathway as a Novel Therapeutic Approach toSDHB-Mutated Cluster I Pheochromocytoma and Paraganglioma
- (2018) Ying Pang et al. CLINICAL CANCER RESEARCH
- Role of DOTATATE-PET/CT in preoperative assessment of phaeochromocytoma and paragangliomas
- (2018) Matti L. Gild et al. CLINICAL ENDOCRINOLOGY
- Efficacy and safety of metyrosine in pheochromocytoma/paraganglioma: a multi-center trial in Japan
- (2018) Mitsuhide Naruse et al. ENDOCRINE JOURNAL
- Unenhanced CT imaging is highly sensitive to exclude pheochromocytoma: a multicenter study
- (2018) Edward Buitenwerf et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Gain-of-function mutations in DNMT3A in patients with paraganglioma
- (2018) Laura Remacha et al. GENETICS IN MEDICINE
- 18F-FDOPA PET/CT Imaging of MAX-Related Pheochromocytoma
- (2018) David Taïeb et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Tumour risks and genotype–phenotype correlations associated with germline variants in succinate dehydrogenase subunit genesSDHB,SDHCandSDHD
- (2018) Katrina A Andrews et al. JOURNAL OF MEDICAL GENETICS
- Preoperative genetic testing in pheochromocytomas and paragangliomas influences the surgical approach and the extent of adrenal surgery
- (2018) Pavel Nockel et al. SURGERY
- Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or DeconjugatedO-Methylated Catecholamine Metabolites
- (2018) Graeme Eisenhofer et al. CLINICAL CHEMISTRY
- Bayesian approach to determining penetrance of pathogenic SDH variants
- (2018) Diana E Benn et al. JOURNAL OF MEDICAL GENETICS
- Risk Stratification on Pheochromocytoma and Paraganglioma from Laboratory and Clinical Medicine
- (2018) Noriko Kimura et al. Journal of Clinical Medicine
- Telomerase Activation and ATRX Mutations Are Independent Risk Factors for Metastatic Pheochromocytoma and Paraganglioma
- (2018) Sylvie Job et al. CLINICAL CANCER RESEARCH
- Can subunit-specific phenotypes guide surveillance imaging decisions in asymptomatic SDH mutation carriers?
- (2018) Nicola Tufton et al. CLINICAL ENDOCRINOLOGY
- Efficacy and Safety of High-Specific-Activity I-131 MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma
- (2018) Daniel A. Pryma et al. JOURNAL OF NUCLEAR MEDICINE
- TARGETED ALPHA PARTICLE THERAPY FOR NEUROENDOCRINE TUMOURS: THE NEXT GENERATION OF PRRT
- (2018) Ashley Grossman et al. NEUROENDOCRINOLOGY
- New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification
- (2017) Joakim Crona et al. ENDOCRINE REVIEWS
- Superiority of 68Ga-DOTATATE over 18F-FDG and anatomic imaging in the detection of succinate dehydrogenase mutation (SDHx )-related pheochromocytoma and paraganglioma in the pediatric population
- (2017) Abhishek Jha et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- SDHB-related pheochromocytoma and paraganglioma penetrance and genotype–phenotype correlations
- (2017) Ivana Jochmanova et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Phase 1 Study of High-Specific-Activity I-131 MIBG for Metastatic and/or Recurrent Pheochromocytoma or Paraganglioma
- (2017) Richard B Noto et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Efficacy of Peptide Receptor Radionuclide Therapy for Functional Metastatic Paraganglioma and Pheochromocytoma
- (2017) Grace Kong et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Malignant Pheochromocytoma and Paraganglioma: 272 Patients Over 55 Years
- (2017) Oksana Hamidi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Functional Imaging Signature of Patients Presenting with Polycythemia/Paraganglioma Syndromes
- (2017) Ingo Janssen et al. JOURNAL OF NUCLEAR MEDICINE
- Peptide Receptor Radionuclide Treatment and (131)I-MIBG in the management of patients with metastatic/progressive phaeochromocytomas and paragangliomas
- (2017) Konstantinos Nastos et al. JOURNAL OF SURGICAL ONCOLOGY
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
- (2017) Jonathan Strosberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- SDHB mutation status and tumor size but not tumor grade are important predictors of clinical outcome in pheochromocytoma and abdominal paraganglioma
- (2017) Yasmine Assadipour et al. SURGERY
- Mitochondrial Complex II: At the Crossroads
- (2017) Ayenachew Bezawork-Geleta et al. TRENDS IN BIOCHEMICAL SCIENCES
- Activating FGFR1 Mutations in Sporadic Pheochromocytomas
- (2017) Jenny Welander et al. WORLD JOURNAL OF SURGERY
- Controlling Tumor Progression with Cyclophosphamide, Vincristine, and Dacarbazine Treatment Improves Survival in Patients with Metastatic and Unresectable Malignant Pheochromocytomas/Paragangliomas
- (2017) Shiko Asai et al. Hormones & Cancer
- Review of Pediatric Pheochromocytoma and Paraganglioma
- (2017) Reshma Bholah et al. Frontiers in Pediatrics
- Pheochromocytoma: The First Metabolic Endocrine Cancer
- (2016) I. Jochmanova et al. CLINICAL CANCER RESEARCH
- Outcomes of annual surveillance imaging in an adult and paediatric cohort of succinate dehydrogenase B mutation carriers
- (2016) Nicola Tufton et al. CLINICAL ENDOCRINOLOGY
- CHARACTERISTICS AND OUTCOMES OF METASTATIC SDHB AND SPORADIC PHEOCHROMOCYTOMA/PARAGANGLIOMA: AN NATIONAL INSTITUTES OF HEALTH STUDY
- (2016) Hana Turkova et al. Endocrine Practice
- Novel insights into the polycythemia–paraganglioma–somatostatinoma syndrome
- (2016) Roland Därr et al. ENDOCRINE-RELATED CANCER
- Interest of systematic screening of pheochromocytoma in patients with neurofibromatosis type 1
- (2016) Lori Képénékian et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Rapid-sequence MRI for long-term surveillance for paraganglioma and phaeochromocytoma in patients with succinate dehydrogenase mutations
- (2016) Eleni Daniel et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma: Table 1
- (2016) P F Plouin et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Von Hippel-Lindau Disease: Genetics and Role of Genetic Counseling in a Multiple Neoplasia Syndrome
- (2016) Sarah M. Nielsen et al. JOURNAL OF CLINICAL ONCOLOGY
- Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study
- (2016) James C Yao et al. LANCET
- Peptide receptor radionuclide therapy for metastatic paragangliomas
- (2016) David J. Pinato et al. MEDICAL ONCOLOGY
- Head and Neck Paragangliomas
- (2016) Michael G. Moore et al. OTOLARYNGOLOGY-HEAD AND NECK SURGERY
- Recurrent Mutations of Chromatin-Remodeling Genes and Kinase Receptors in Pheochromocytomas and Paragangliomas
- (2015) R. A. Toledo et al. CLINICAL CANCER RESEARCH
- Superiority of [68Ga]-DOTATATE PET/CT to Other Functional Imaging Modalities in the Localization of SDHB-Associated Metastatic Pheochromocytoma and Paraganglioma
- (2015) I. Janssen et al. CLINICAL CANCER RESEARCH
- Peptide receptor radionuclide therapy with 90Y/177Lu-labelled peptides for inoperable head and neck paragangliomas (glomus tumours)
- (2015) Ameya D. Puranik et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prospective comparison of 68Ga-DOTATATE and 18F-FDOPA PET/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases
- (2015) Aurélien Archier et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 68Ga-DOTATATE PET/CT in the Localization of Head and Neck Paragangliomas Compared with Other Functional Imaging Modalities and CT/MRI
- (2015) I. Janssen et al. JOURNAL OF NUCLEAR MEDICINE
- Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
- (2015) Samuel A. Wells et al. THYROID
- Profiling of Somatic Mutations in Phaeochromocytoma and Paraganglioma by Targeted Next Generation Sequencing Analysis
- (2015) Andrea Luchetti et al. International Journal of Endocrinology
- Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas
- (2015) Lauren Fishbein et al. Nature Communications
- The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort study
- (2014) Jan Schovanek et al. BMC CANCER
- Treatment of malignant phaeochromocytoma with a combination of cyclophosphamide, vincristine and dacarbazine: own experience and overview of the contemporary literature
- (2014) Timo Deutschbein et al. CLINICAL ENDOCRINOLOGY
- Chemotherapy with cyclophosphamide, vincristine and dacarbazine for malignant paraganglioma and pheochromocytoma: systematic review and meta-analysis
- (2014) N.D. Niemeijer et al. CLINICAL ENDOCRINOLOGY
- Current Approaches and Recent Developments in the Management of Head and Neck Paragangliomas
- (2014) David Taïeb et al. ENDOCRINE REVIEWS
- Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma
- (2014) Noriko Kimura et al. ENDOCRINE-RELATED CANCER
- Combination of 13-CisRetinoic Acid and Lovastatin: Marked Antitumor Potential In Vivo in a Pheochromocytoma Allograft Model in Female Athymic Nude Mice
- (2014) Svenja Nölting et al. ENDOCRINOLOGY
- Clinical utility of chromogranin A inSDHx-related paragangliomas
- (2014) Samuel Zuber et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- SDHBmutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma
- (2014) Julien Hadoux et al. INTERNATIONAL JOURNAL OF CANCER
- Opposing effects of HIF1α and HIF2α on chromaffin cell phenotypic features and tumor cell proliferation: Insights from MYC-associated factor X
- (2014) Nan Qin et al. INTERNATIONAL JOURNAL OF CANCER
- Treatment of Head and Neck Paragangliomas With External Beam Radiation Therapy
- (2014) Charles Dupin et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- The Clinical Phenotype ofSDHC-Associated Hereditary Paraganglioma Syndrome (PGL3)
- (2014) Tobias Else et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Rare Germline Mutations Identified by Targeted Next-Generation Sequencing of Susceptibility Genes in Pheochromocytoma and Paraganglioma
- (2014) Jenny Welander et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
- (2014) Jacques W. M. Lenders et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study
- (2014) Frederic Castinetti et al. LANCET ONCOLOGY
- Closing the GAPP on predicting metastases
- (2014) Graeme Eisenhofer et al. Nature Reviews Endocrinology
- Paraganglioma and phaeochromocytoma: from genetics to personalized medicine
- (2014) Judith Favier et al. Nature Reviews Endocrinology
- Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
- (2014) Martyn E. Caplin et al. NEW ENGLAND JOURNAL OF MEDICINE
- External Beam Radiation Therapy in Treatment of Malignant Pheochromocytoma and Paraganglioma
- (2014) Jennifer Vogel et al. Frontiers in Oncology
- The Presence of SDHB Mutations Should Modify Surgical Indications for Carotid Body Paragangliomas
- (2013) Ryan J. Ellis et al. ANNALS OF SURGERY
- SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma
- (2013) Eric Letouzé et al. CANCER CELL
- Biochemical diagnosis of phaeochromocytoma using plasma-free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions
- (2013) Roland Därr et al. CLINICAL ENDOCRINOLOGY
- 131I-MIBG therapy for malignant paraganglioma and phaeochromocytoma: systematic review and meta-analysis
- (2013) L. T. van Hulsteijn et al. CLINICAL ENDOCRINOLOGY
- The management of head-and-neck paragangliomas
- (2013) Cristina Capatina et al. ENDOCRINE-RELATED CANCER
- Long-term prognosis of patients with pediatric pheochromocytoma
- (2013) Birke Bausch et al. ENDOCRINE-RELATED CANCER
- Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas
- (2013) Luis Jaime Castro-Vega et al. HUMAN MOLECULAR GENETICS
- Surgical resection of multiple liver metastasis of functional malignant pheochromocytoma: A case report and literature review
- (2013) Dongde Wu et al. Journal of Cancer Research and Therapeutics
- Bone Metastases and Skeletal-Related Events in Patients With Malignant Pheochromocytoma and Sympathetic Paraganglioma
- (2013) Montserrat Ayala-Ramirez et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- New Syndrome of Paraganglioma and Somatostatinoma Associated With Polycythemia
- (2013) Karel Pacak et al. JOURNAL OF CLINICAL ONCOLOGY
- Response after Surgical Resection of Metastatic Pheochromocytoma and Paraganglioma: Can Postoperative Biochemical Remission Be Predicted?
- (2013) Ryan J. Ellis et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Hypoxia-Inducible Factor Signaling in Pheochromocytoma: Turning the Rudder in the Right Direction
- (2013) I. Jochmanova et al. JNCI-Journal of the National Cancer Institute
- High-Throughput Screening for Growth Inhibitors Using a Yeast Model of Familial Paraganglioma
- (2013) Irina Bancos et al. PLoS One
- Combination Chemotherapy with Cyclophosphamide, Vincristine, and Dacarbazine in Patients with Malignant Pheochromocytoma and Paraganglioma
- (2013) Akiyo Tanabe et al. Hormones & Cancer
- Phase 2 study of everolimus monotherapy in patients with nonfunctioning neuroendocrine tumors or pheochromocytomas/paragangliomas
- (2012) Do-Youn Oh et al. CANCER
- MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma
- (2012) N. Burnichon et al. CLINICAL CANCER RESEARCH
- Evaluation of SDHB, SDHD and VHL gene susceptibility testing in the assessment of individuals with non-syndromic phaeochromocytoma, paraganglioma and head and neck paraganglioma
- (2012) Mariam Jafri et al. CLINICAL ENDOCRINOLOGY
- Signaling Pathways in Pheochromocytomas and Paragangliomas: Prospects for Future Therapies
- (2012) Svenja Nölting et al. ENDOCRINE PATHOLOGY
- Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-DOTATATE in Individuals with Neck or Mediastinal Paraganglioma (PGL)
- (2012) S. Zovato et al. HORMONE AND METABOLIC RESEARCH
- An Update on the Genetics of Paraganglioma, Pheochromocytoma, and Associated Hereditary Syndromes
- (2012) A.-P. Gimenez-Roqueplo et al. HORMONE AND METABOLIC RESEARCH
- Treatment with Sunitinib for Patients with Progressive Metastatic Pheochromocytomas and Sympathetic Paragangliomas
- (2012) Montserrat Ayala-Ramirez et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Combined blockade of signalling pathways shows marked anti-tumour potential in phaeochromocytoma cell lines
- (2012) Svenja Nölting et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- SomaticHIF2AGain-of-Function Mutations in Paraganglioma with Polycythemia
- (2012) Zhengping Zhuang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas
- (2011) Montserrat Ayala-Ramirez et al. CANCER
- Measurements of Plasma Methoxytyramine, Normetanephrine, and Metanephrine as Discriminators of Different Hereditary Forms of Pheochromocytoma
- (2011) G. Eisenhofer et al. CLINICAL CHEMISTRY
- False-negative 123I-MIBG SPECT is most commonly found in SDHB-related pheochromocytoma or paraganglioma with high frequency to develop metastatic disease
- (2011) Jay S Fonte et al. ENDOCRINE-RELATED CANCER
- Plasma methoxytyramine: A novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status
- (2011) Graeme Eisenhofer et al. EUROPEAN JOURNAL OF CANCER
- Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma
- (2011) Nelly Burnichon et al. HUMAN MOLECULAR GENETICS
- Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [90Y-DOTA]-TOC in Metastasized Neuroendocrine Cancers
- (2011) Anna Imhof et al. JOURNAL OF CLINICAL ONCOLOGY
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
- (2011) Eric Raymond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Everolimus for Advanced Pancreatic Neuroendocrine Tumors
- (2011) James C. Yao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adrenal Imaging
- (2010) Michael A. Blake et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma
- (2010) G. Eisenhofer et al. ENDOCRINE-RELATED CANCER
- Spectrum and Prevalence of FP/TMEM127 Gene Mutations in Pheochromocytomas and Paragangliomas
- (2010) Li Yao et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Germline mutations in TMEM127 confer susceptibility to pheochromocytoma
- (2010) Yuejuan Qin et al. NATURE GENETICS
- Genotype-phenotype correlations in VHL exon deletions
- (2009) Alisdair McNeill et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Clinical Utility of Temozolomide in the Treatment of Malignant Paraganglioma: A Preliminary Report
- (2009) E. L. Bravo et al. HORMONE AND METABOLIC RESEARCH
- Novel and Evolving Therapies in the Treatment of Malignant Phaeochromocytoma: Experience with the mTOR Inhibitor Everolimus (RAD001)
- (2009) M. R. Druce et al. HORMONE AND METABOLIC RESEARCH
- Phase II Study of High-Dose [131I]Metaiodobenzylguanidine Therapy for Patients With Metastatic Pheochromocytoma and Paraganglioma
- (2009) Sara Gonias et al. JOURNAL OF CLINICAL ONCOLOGY
- Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
- (2009) Anja Rinke et al. JOURNAL OF CLINICAL ONCOLOGY
- An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis
- (2009) Francien H van Nederveen et al. LANCET ONCOLOGY
- Expression of neuropeptide hormone receptors in human adrenal tumors and cell lines: Antiproliferative effects of peptide analogues
- (2009) C. G. Ziegler et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Differential expression of the regulated catecholamine secretory pathway in different hereditary forms of pheochromocytoma
- (2008) Graeme Eisenhofer et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine
- (2008) Hui Huang et al. CANCER
- Clinical manifestations of familial paraganglioma and phaeochromocytomas insuccinate dehydrogenase B(SDH-B) gene mutation carriers
- (2008) Umasuthan Srirangalingam et al. CLINICAL ENDOCRINOLOGY
- The kinesin KIF1B acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor
- (2008) S. Schlisio et al. GENES & DEVELOPMENT
- Biochemically Silent Abdominal Paragangliomas in Patients with Mutations in theSuccinate Dehydrogenase Subunit BGene
- (2008) Henri J. L. M. Timmers et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis
- (2008) Vivian E. Strong et al. SURGERY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started